Anaplastic Oligodendroglioma
Showing NaN - NaN of 7
Anaplastic Astrocytoma, Anaplastic Ependymoma, Anaplastic Oligodendroglioma Trial in United States (other, drug, procedure)
Active, not recruiting
- Anaplastic Astrocytoma
- +6 more
- Laboratory Biomarker Analysis
- +4 more
-
Los Angeles, California
- +11 more
Jul 1, 2022
Anaplastic Oligodendroglioma, Oligoastrocytoma, Oligodendroglioma Trial in Los Angeles (Wear novoTTF-200A, Quality-of-Life
Withdrawn
- Anaplastic Oligodendroglioma
- +2 more
- Wear novoTTF-200A
- Quality-of-Life Assessment
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Dec 8, 2020
Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in United States (Toca 511, Toca FC)
Completed
- Glioblastoma Multiforme
- +3 more
- Toca 511
- Toca FC
-
Irvine, California
- +5 more
May 16, 2018
Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in United States (Toca 511 vector, Toca FC)
Completed
- Glioblastoma Multiforme
- +3 more
- Toca 511 vector
- Toca FC
-
Los Angeles, California
- +7 more
May 16, 2018
Teratoid Tumor, Atypical, Choroid Plexus Tumors, Anaplastic Astrocytoma Trial in United States (azurin-derived cell-penetrating
Completed
- Teratoid Tumor, Atypical
- +9 more
- azurin-derived cell-penetrating peptide p28
-
Los Angeles, California
- +10 more
Aug 3, 2017
Gliomas, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in Los Angeles (alloreactive CTL)
Completed
- Gliomas
- +5 more
- alloreactive CTL
-
Los Angeles, CaliforniaUniversity of California, Los Angeles
May 26, 2016